Photo of Aubrey Stoddard

Aubrey Stoddard

Aubrey Stoddard is an associate in the firm’s Washington, DC office, where she is a member of the Health Care Practice Group. Aubrey advises pharmaceutical, biotechnology, and medical device clients on a broad range of policy and regulatory issues.

Aubrey also maintains an active pro bono practice centered on reproductive health.

On 2 April 2026, the UK Government published text memorializing its agreement with the U.S. in relation to pharmaceutical pricing.  The UK now refers to this as an “arrangement” (“U.S.-UK Pharmaceutical Pricing Arrangement”).  Our blog post from December discussed the in-principle heads of terms for the deal announced

Continue Reading U.S.–UK Pharmaceutical Pricing Agreement: Learnings from the Published Text